Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

Delayed Data
As of Dec 02
 +0.21 / +1.13%
Today’s Change
Today|||52-Week Range
How to Buy GlaxoSmithKline at a 15% Discount
Dec 02 / TheStreet.com - Paid Partner Content
Merck: Keytruda's Priority Review for New Cancer Indication
Nov 29 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
Tweedy Browne Fund Investment Adviser's Semi-Annual Letter to Shareholders
Nov 28 / GuruFocus News - Paid Partner Content
Jeff Auxier Curbs Multiple Positions in 3rd Quarter
Dec 01 / GuruFocus News - Paid Partner Content
Glaxo (GSK) Files Regulatory Application for Shingrix in EU
Nov 28 / Zacks.com - Paid Partner Content
Here's the Best Dividend Stock in Big Pharma
Dec 01 / MotleyFool.com - Paid Partner Content
Glaxo Nucala Favorable in Rare Vasculitis Disease Study
Nov 24 / Zacks.com - Paid Partner Content
10 Undervalued High-Yield Dividend Stocks Worth Buying Today
Nov 30 / TheStreet.com - Paid Partner Content
3 Potentially Huge Catalysts for Ionis Pharmaceuticals, Inc. in 2017
Nov 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close18.51
Today’s open18.55
Day’s range18.55 - 18.83
Average volume (3 months)3,677
Market cap$91.3B
Dividend yield5.32%
Data as of 3:35pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--


Health Technology
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --


Search for Jobs